A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

author
Lal, Anoushka P.
Foong, Yi Chao
Sanfilippo, Paul G.
Spelman, Tim
Rath, Louise
Levitz, David
Fabis-Pedrini, Marzena
Foschi, Matteo
Habek, Mario
statement of authorship
Lal, Anoushka P.; Foong, Yi Chao; Sanfilippo, Paul G.; Spelman, Tim; Rath, Louise; Levitz, David; Fabis-Pedrini, Marzena; Foschi, Matteo; Habek, Mario; Kalincik, Tomas; Roos, Izanne; Lechner-Scott, Jeannette; John, Nevin; Soysal, Aysun; D'Amico, Emanuele; Gouider, Riadh; Mrabet, Saloua; Gross-Paju, Katrin; Cardenas-Robledo, Simon; Moghadasi, Abdorreza Naser; Sa, Maria Jose; Gray, Orla; Oh, Jiwon; Reddel, Stephen; Ramanathan, Sudarshini; Al-Harbi, Talal; Altintas, Ayse; Hardy, Todd A.; Ozakbas, Serkan; Alroughani, Raed; Kermode, Allan G.; Surcinelli, Andrea; Laureys, Guy; Eichau, Sara; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Hodgkinson, Suzanne; Ramo-Tello, Cristina; Maimone, Davide; Mccombe, Pamela; Spitaleri, Daniele; Sanchez-Menoyo, Jose Luis; Yetkin, Mehmet Fatih; Baghbanian, Seyed Mohammad; Karabudak, Rana; Al-Asmi, Abdullah; Jakob, Gregor Brecl; Khoury, Samia J.; Etemadifar, Masoud; van Pesch, Vincent; Buzzard, Katherine; Taylor, Bruce; Butzkueven, Helmut; Van der Walt, Anneke
publisher
Springer Heidelberg
journal volume number month
vol. 271
year of publication
pages
12, p. 5813-5824 : ill
ISSN
1432-1459
0340-5354
notes
Bibliogr.: 39 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
language
inglise
keyword
disease-modifying therapy
anti-CD20 monoclonal antibodies
cladribine
Natalizumab
Lal, A.P., Foong, Y.C., Sanfilippo, P.G., Spelman, T., Rath, L., Levitz, D., Fabis-Pedrini, M., Foschi, M., Habek, M., Gross-Paju, K. et al. A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic // Journal of Neurology (2024) vol. 271, 12, p. 5813-5824 : ill. https://doi.org/10.1007/s00415-024-12518-7